skip to main content

Explore Research Products in the NSF-PAR

  • NSF Public Access
  • Search Results
  • The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis
Title: The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis
Award ID(s):
2125677
NSF-PAR ID:
10351182
Author(s) / Creator(s):
; ; ; ; ; ;
Date Published:
Journal Name:
Vaccine
Volume:
40
Issue:
14
ISSN:
0264-410X
Page Range / eLocation ID:
2209 to 2214
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; ( , Frontiers in Immunology)
    null (Ed.)
    The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants answered questions on vaccine hesitancy and responded if they would accept the vaccine given different safety and effectiveness profiles. We assessed differences in COVID-19 rejection and general vaccine hesitancy through logistic regressions. Among 713 participants, 33.0% were vaccine hesitant, and 18.4% would reject a COVID-19 vaccine. Acceptance varied by effectiveness profile: 10.2% would reject a 95% effective COVID-19 vaccine, but 32.4% would reject a 50% effective vaccine. Those vaccine hesitant were significantly more likely to reject COVID-19 vaccination [odds ratio (OR): 5.56, 95% confidence interval (CI): 3.39, 9.11]. In multivariable logistic regression models, there were similar patterns for vaccine hesitancy and COVID-19 vaccine rejection by gender, race/ethnicity, family income, and political affiliation. But the direction of association flipped by urbanicity (P=0.0146, with rural dwellers less likely to be COVID-19 vaccine rejecters but more likely to be vaccine hesitant in general), and age (P=0.0037, with fewer pronounced differences across age for COVID-19 vaccine rejection, but a gradient of stronger vaccine hesitancy in general among younger ages). During the COVID-19 epidemic’s early phase, patterns of vaccine hesitancy and COVID-19 vaccine rejection were relatively similar. A significant minority would reject a COVID-19 vaccine, especially one with less-than-ideal effectiveness. Preparations for introducing the COVID-19 vaccine should anticipate substantial hesitation and target concerns, especially among younger adults. 
    more » « less
  2. ; ; ; ; ( , Human Vaccines & Immunotherapeutics)
    null (Ed.)
    This study examined whether future COVID-19 vaccine acceptance differed based on an experimental manipulation of the vaccine safety and effectiveness profile. Data come from the Detroit Metro Area Community Study, a population-based study conducted July 15–20, 2020. Participants were asked whether they would get a new COVID-19 vaccine after being randomly assigned information about the vaccine’s effectiveness (50% or 95%) and chance of fever (5% or 20%). Among 1,117 Detroiters, 51.3% would accept a COVID-19 vaccine that is 50% effective and 77.1% would accept a vaccine that is 95% effective. Women and adults ≥65 were more accepting of a vaccine; Black Detroiters were less accepting. Believing vaccines to be important, effective, and safe was associated with higher acceptance. Uptake of a COVID-19 may be limited, depending on perceived vaccine effectiveness and general attitudes toward vaccines. Public health approaches to modifying these attitudes will be especially important in the Black community. 
    more » « less
  3. ; ; ; ; ; ; ; ; ( , Vaccines)
    Controlling the spread of SARS-CoV-2 will require high vaccination coverage, but acceptance of the vaccine could be impacted by perceptions of vaccine safety and effectiveness. The aim of this study was to characterize how vaccine safety and effectiveness impact acceptance of a vaccine, and whether this impact varied over time or across socioeconomic and demographic groups. Repeated cross-sectional surveys of an opt-in internet sample were conducted in 2020 in the US, mainland China, Taiwan, Malaysia, Indonesia, and India. Individuals were randomized into receiving information about a hypothetical COVID-19 vaccine with different safety and effectiveness profiles (risk of fever 5% vs. 20% and vaccine effectiveness 50% vs. 95%). We examined the effect of the vaccine profile on vaccine acceptance in a logistic regression model, and included interaction terms between vaccine profile and socioeconomic/demographic variables to examine the differences in sensitivity to the vaccine profile. In total, 12,915 participants were enrolled in the six-country study, including the US (4054), China (2797), Taiwan (1278), Malaysia (1497), Indonesia (1527), and India (1762). Across time and countries, respondents had stronger preferences for a safer and more effective vaccine. For example, in the US in November 2020, acceptance was 3.10 times higher for a 95% effective vaccine with a 5% risk of fever, vs a vaccine 50% effective, with a 20% risk of fever (95% CI: 2.07, 4.63). Across all countries, there was an increase in the effect of the vaccine profile over time (p < 0.0001), with stronger preferences for a more effective and safer vaccine in November 2020 compared to August 2020. Sensitivity to the vaccine profile was also stronger in August compared to November 2020, in younger age groups, among those with lower income; and in those that are vaccine hesitant. Uptake of COVID-19 vaccines could vary in a country based upon effectiveness and availability. Effective communication tools will need to be developed for certain sensitive groups, including young adults, those with lower income, and those more vaccine hesitant. 
    more » « less
  4. ( , COMPTEXT 2023)
    Conference panel presentation 
    more » « less
  5. ; ; ; ( , Transportation Science)
    Since the start of the COVID-19 pandemic, disruptions have been experienced in many supply chains, particularly in personal protective equipment, testing kits, and even essential household goods. Effective vaccines to protect against COVID-19 were approved for emergency use in the United States in late 2020, which led to one of the most extensive vaccination campaigns in history. We continuously collect data on vaccine allocation, shipment and distribution, administration, and inventory in the United States, covering the entire vaccination campaign. In this article, we describe some data sets that we collaborated to obtain. We are publishing the data and making them freely available to researchers, media organizations, and other stakeholders so that others may use the data to develop insights about the distribution and wastage of vaccines during the current pandemic or to provide an informed future pandemic response. This article gives an overview of vaccine distribution logistics in the United States, describes the data we obtain, outlines how they may be accessed and used by others, and describes some high-level analyses demonstrating some aspects of the data (for data collected during January 1, 2021–March 31, 2021). This article also provides directions for future research using the collected data. Our goal is two-fold: (i) We would like the data to be used in many creative ways to inform the current and future pandemic response. (ii) We also want to inspire other researchers to make their data publicly available in a timely manner. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email